Assobiotec - English version

13 January 2021

Novamont acquires BioBag and strengthens its leadership and global presence

The operation creates the most vertically integrated group in the bioplastics industry and allows the Italian B-Corp to further expand into Northern/Eastern Europe, North America and Australia

12 January 2021

JPM Healthcare Conference - Italy on the move 2021

During the JPM Conference 2021 (11-14 January), ITA - Italian Trade Agency in conjunction with the Ministry of Foreign Affairs organizes collateral digital events to present the LifeSciences and Pharmaceutical excellence in Italy

21 December 2020

Axxam and Symeres To Offer an Innovative Compound Library for High-Throughput Screens

Symeres and Axxam have further consolidated their strategic relationship, providing integrated drug discovery and development services to clients around the world, by announcing the transfer of a library of approx. 80,000 lead-like compounds, Symegold, to Axxam for use in high-throughput screens

24 November 2020

Reithera announces its GRAd-COV2 COVID-19 vaccine candidate is well tolerated and induces clear immune responses in healthy subject aged 18-55 years phase 1 trial to advance into elderly subjects aged 65-85 years

ReiThera provides an update on the ongoing Phase 1 study of its vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2)

Coronavirus

23 November 2020

Genenta to appoint Stephen Squinto, experienced biotech executive and investor, as Chairman

The appointment will be effective with the approval of the Genenta Shareholders’ Meeting.

10 November 2020

Three areas of intervention and twenty-three proposals: a plan for biotech and for Italy

The plan is the final stage of a journey begun last spring that put together companies, start-ups, institutions, research bodies and trade/citizens associations. One objective: to outline concrete and widely-shared policy proposals and action plans for the future of the sector and of Italy

The Italian Biotech Industry

News

Novamont acquires BioBag and strengthens its leadership and global presence

JPM Healthcare Conference - Italy on the move 2021

Axxam and Symeres To Offer an Innovative Compound Library for High-Throughput Screens

Reithera announces its GRAd-COV2 COVID-19 vaccine candidate is well tolerated and induces clear immune responses in healthy subject aged 18-55 years phase 1 trial to advance into elderly subjects aged 65-85 years

Genenta to appoint Stephen Squinto, experienced biotech executive and investor, as Chairman

Three areas of intervention and twenty-three proposals: a plan for biotech and for Italy

Partner

Where to find us

The Italian Biotech Industry

News

Novamont acquires BioBag and strengthens its leadership and global presence

JPM Healthcare Conference - Italy on the move 2021

Axxam and Symeres To Offer an Innovative Compound Library for High-Throughput Screens

Reithera announces its GRAd-COV2 COVID-19 vaccine candidate is well tolerated and induces clear immune responses in healthy subject aged 18-55 years phase 1 trial to advance into elderly subjects aged 65-85 years

Genenta to appoint Stephen Squinto, experienced biotech executive and investor, as Chairman

Three areas of intervention and twenty-three proposals: a plan for biotech and for Italy

Partner

Where to find us

Our site uses cookies